Delong Liu

12.9k total citations · 1 hit paper
189 papers, 9.1k citations indexed

About

Delong Liu is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Delong Liu has authored 189 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Oncology, 59 papers in Molecular Biology and 55 papers in Hematology. Recurrent topics in Delong Liu's work include Acute Myeloid Leukemia Research (30 papers), CAR-T cell therapy research (30 papers) and Lymphoma Diagnosis and Treatment (29 papers). Delong Liu is often cited by papers focused on Acute Myeloid Leukemia Research (30 papers), CAR-T cell therapy research (30 papers) and Lymphoma Diagnosis and Treatment (29 papers). Delong Liu collaborates with scholars based in United States, China and Singapore. Delong Liu's co-authors include Shundong Cang, Yongping Song, Yongping Song, Guoqing Wei, Juanjuan Zhao, Nikhil Mukhi, Akintunde Akinleye, Muhammad Furqan, Jingjing Wu and Kemeng Wang and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Delong Liu

181 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Combination strategies to maximize the benefits of cancer immunotherapy

2021 442 citations Delong Liu et al. Journal of Hematology & Oncology profile →

Peers

Delong Liu

MB

ONCOL

IMMUN

GENET

HEMAT

Luigi Maria Larocca Italy

Raymond Lai Canada

Ann T. Farrell United States

Anne‐Marie Mes‐Masson Canada

Jane L. Liesveld United States

Shinya Kimura Japan

Susan M. Blaney United States

Yoshiro Niitsu Japan

Ken H. Young United States

Sandrine Faivre France

Luigi Maria Larocca Italy

Delong Liu

3.5k ×0.9

MB

3.3k ×0.9

ONCOL

1.1k ×0.6

IMMUN

2.2k ×1.7

GENET

831 ×0.6

HEMAT

Citations per year, relative to Delong Liu Delong Liu (= 1×) peers Luigi Maria Larocca

Countries citing papers authored by Delong Liu

Since Specialization

Citations

This map shows the geographic impact of Delong Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Delong Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Delong Liu more than expected).

Fields of papers citing papers by Delong Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Delong Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Delong Liu. The network helps show where Delong Liu may publish in the future.

Co-authorship network of co-authors of Delong Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Delong Liu. A scholar is included among the top collaborators of Delong Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Delong Liu. Delong Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Wang, Yuyin, Yue Wang, Xuehui Zhang, et al.. (2025). A zero-dimensional hybrid halide with superior water resistance for high-efficiency X-ray scintillation and solid-state lighting. Journal of Materials Chemistry C. 13(16). 8320–8327. 2 indexed citations

2.

Wang, Zhengying, Jinghong Liu, Yu Wang, et al.. (2023). Effects of oral cysteine leukotriene receptor antagonist-montelukast on adenoid lymphoid tissue: a histopathological study under light microscope. Frontiers in Pharmacology. 14. 1285647–1285647. 2 indexed citations

3.

Ahmed, Tauseef, et al.. (2023). Equity and Resource Allocation: The Case for Allogeneic Transplant in Emergency Medicaid Patients. Blood. 142(Supplement 1). 7349–7349.

4.

Saal, Talia M., Christine Pellegrino, Tauseef Ahmed, et al.. (2023). Calr+ Myelofibrosis/BCR-ABL Chronic Myeloid Leukemia Overlap Syndrome Treated with Asciminib. Blood. 142(Supplement 1). 6423–6423. 1 indexed citations

5.

Huang, Yang, et al.. (2023). Dynamic spectrum anti-jamming with distributed learning and transfer learning. China Communications. 20(12). 52–65.

6.

Liu, Delong, et al.. (2021). Potential genes and pathways associated with heterotopic ossification derived from analyses of gene expression profiles. Journal of Orthopaedic Surgery and Research. 16(1). 499–499. 7 indexed citations

7.

Ahmed, Jibran, et al.. (2021). The Safety and Efficacy of Granulocyte Transfusions in Pediatric Recipients with Severe Neutropenia. Blood. 138(Supplement 1). 2148–2148. 1 indexed citations

8.

Liu, Delong, et al.. (2021). Factors influencing the reference interval of thyroid‐stimulating hormone in healthy adults: A systematic review and meta‐analysis. Clinical Endocrinology. 95(3). 378–389. 9 indexed citations

9.

Zou, Zhiyuan, Le Wang, Qing Sun, et al.. (2020). Simultaneous incorporation of PTH(1–34) and nano-hydroxyapatite into Chitosan/Alginate Hydrogels for efficient bone regeneration. Bioactive Materials. 6(6). 1839–1851. 93 indexed citations

10.

Ling, Zemin, Liangping Li, Hao Hu, et al.. (2020). Changes of the end plate cartilage are associated with intervertebral disc degeneration: A quantitative magnetic resonance imaging study in rhesus monkeys and humans. Journal of Orthopaedic Translation. 24. 23–31. 19 indexed citations

11.

Agarwal, Anup, et al.. (2017). Babesiosis-associated immune thrombocytopenia. PubMed. 4. 1–1. 13 indexed citations

12.

Liu, Delong, et al.. (2017). Diagnosis and treatment of CD20 negative B cell lymphomas. Biomarker Research. 5(1). 5–5. 20 indexed citations

13.

Liu, Delong, et al.. (2017). Syk inhibitors in clinical development for hematological malignancies. Journal of Hematology & Oncology. 10(1). 145–145. 124 indexed citations

14.

Liu, Delong, et al.. (2017). Autoimmune hemolytic anemia associated with babesiosis. Biomarker Research. 5(1). 14–14. 19 indexed citations

15.

Geng, Li‐Na, Xianglin Duan, Yan Wang, et al.. (2016). Quantum dots-hemin: Preparation and application in the absorption of heme iron. Nanomedicine Nanotechnology Biology and Medicine. 12(7). 1747–1755. 8 indexed citations

16.

Cang, Shundong, et al.. (2015). ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development. Journal of Hematology & Oncology. 8(1). 129–129. 221 indexed citations

17.

Mehta, Bella, et al.. (2014). CEPP regimen (cyclophosphamide, etoposide, procarbazine and prednisone) as initial treatment for Hodgkin lymphoma patients presenting with severe abnormal liver function. Biomarker Research. 2(1). 12–12. 4 indexed citations

18.

Akinleye, Akintunde, et al.. (2013). MEK and the inhibitors: from bench to bedside. Journal of Hematology & Oncology. 6(1). 27–27. 236 indexed citations

19.

Tan, Jiahuai, et al.. (2009). t(3;9;22) 3-Way Chromosome Translocation in Chronic Myeloid Leukemia is Associated with Poor Prognosis. Cancer Investigation. 27(7). 718–722. 5 indexed citations

20.

Seiter, Karen, Anila Qureshi, Delong Liu, et al.. (2005). Severe toxicity following induction chemotherapy for acute myelogenous leukemia in a patient with Werner's syndrome. Leukemia & lymphoma. 46(7). 1091–1095. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact